USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults Ruchika Sharma21 Dec 2023 3:47 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
USFDA declines to approve Merck chronic cough drug Gefapixant Ruchika Sharma21 Dec 2023 11:30 AM ISTNew Jersey: The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday,...
Merck bags USFDA nod for Keytruda, Padcev combo for urothelial cancer Ruchika Sharma18 Dec 2023 1:45 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
Merck Welireg gets USFDA approval for kidney cancer Ruchika Sharma15 Dec 2023 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck Animal Health receives positive CVMP opinion for injectable formulation of Bravecto for dogs Ruchika Sharma12 Dec 2023 4:30 PM ISTBased on the CVMP's recommendation, the EC is expected to issue a decision for marketing authorization in the European Union during the first quarter...
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
Merck-Eisai endometrial cancer therapy combo fails first-line treatment trial Ruchika Sharma9 Dec 2023 1:30 PM ISTRahway: Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line...
Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients Ruchika Sharma8 Dec 2023 3:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...
Merck KGaA multiple sclerosis drug fails in late-stage trials Ruchika Sharma7 Dec 2023 3:30 PM ISTFrankfurt: Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a...
Merck application for Keytruda plus Padcev for Urothelial Cancer gets USFDA priority review Ruchika Sharma2 Dec 2023 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted...
Merck 21-valent Pneumococcal Conjugate Vaccine demonstrates superior immunogenicity for 10 of 11 Unique Serotypes compared to PCV20 in adults 50 years of age and older Ruchika Sharma30 Nov 2023 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced results from STRIDE-3, a Phase 3 trial evaluating V116, the...
Merck to acquire Caraway Therapeutics for up to USD 610 million Ruchika Sharma23 Nov 2023 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. have announced that the companies have...
